相关实验视频

Updated: Jan 18, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

达丁类药物对慢性淋巴细胞白血病细胞IL-10信号传递和产生的影响

Guizhi Wang¹, Tina YuXuan Luo^1,2, Yonghong Shi¹

¹Biology Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Journal of immunology (Baltimore, Md. : 1950)

|June 2, 2025

概括

类他类药物通过影响胆固醇生物合成,抑制慢性淋巴细胞白血病 (CLL) B 细胞中的互白素-10 生产. 这表明了CLL的潜在治疗策略,可能需要组合治疗以获得最佳的临床益处.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物化学生化学

背景情况:

卢克索利提尼布是一种细胞因子信号传递抑制剂,可以在慢性淋巴细胞白血病 (CLL) 中引发疾病爆发.
这种效应与激活的CLL B细胞 (2S细胞) 减少交白素-10 (IL-10) 的产生有关.
在正常的B细胞中,IL-10的产生受到胆固醇生物合成的影响,可以通过他类药物调节.

研究的目的:

研究他类药物对激活的CLL B细胞 (2S细胞) 中IL-10产生的影响.
探索胆固醇生物合成和前化在调节CLL中的IL-10产生中的作用.

主要方法:

激活的CLL B细胞 (2S细胞) 接受了他类药物治疗.
分析了IL-10产生,MYC激活和下游信号通路的变化.
评估了geranylgeranyl pyrophosphate补充剂对纠正他类药物诱导的缺陷的影响.

主要成果:

脂友性他类药物显著降低了2S CLL细胞中的IL-10产量.
类固醇治疗抑制了MYC激活和对IL-10转录至关重要的二次信号传递.
在用geranylgeranyl pyrophosphate纠正前化缺陷后,IL-10产生的恢复发生了.
活体内由鲁克索利提尼布激活的CLL细胞表现出与prenylation抑制相关的基因丰富.

结论:

在激活的CLL细胞中,IL-10的产生部分由胆固醇生物合成通过geranylgeranyl pyrophosphate和基质前enylation来调节.
类药物显示出一种潜在的机制来调节CLL中的IL-10.
对于CLL,他类药物的临床应用可能需要与其他药物同时使用,以提高疗效.

关键词:

在 IL-10 中,IL-10 是 IL-10 的代表.我的世界 MYC 收费类受体的收费类受体.慢性淋巴细胞白血病慢性淋巴细胞白血病类药物类药物类药物

更多相关视频

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Published on: September 2, 2014

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Published on: April 14, 2010

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...